phosphatidylcholines has been researched along with sulfaphenazole in 1 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (sulfaphenazole) | Trials (sulfaphenazole) | Recent Studies (post-2010) (sulfaphenazole) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 365 | 8 | 96 |
Protein | Taxonomy | phosphatidylcholines (IC50) | sulfaphenazole (IC50) |
---|---|---|---|
Cytochrome P450 2C9 | Homo sapiens (human) | 1.3731 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barron, A; Caldwell, GA; Caldwell, KA; Galiano, F; Lee, YJ; Patel, D; Wang, S; Witt, SN; Xu, C; Zhang, S | 1 |
1 other study(ies) available for phosphatidylcholines and sulfaphenazole
Article | Year |
---|---|
Chemical Compensation of Mitochondrial Phospholipid Depletion in Yeast and Animal Models of Parkinson's Disease.
Topics: alpha-Synuclein; Animals; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Carboxy-Lyases; Cyclosporine; Disease Models, Animal; Dopaminergic Neurons; Endoplasmic Reticulum Stress; Meclofenoxate; Membrane Proteins; Mitochondria; Mitochondrial Proteins; Parkinson Disease; Phosphatidylcholines; Phosphatidylethanolamines; Protective Agents; Saccharomyces cerevisiae; Solubility; Sulfaphenazole; Transferases (Other Substituted Phosphate Groups) | 2016 |